PURISYS LLC

Overview

PURISYS LLC is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering CANNABIDIOL DRUG SUBSTANCE; DEXMETHYLPHENIDATE HYDROCHLORIDE; DRONABINOL DRUG SUBSTANCE; DRONABINOL DRUG SUBSTANCE IN SESAME OIL; NABILONE DRUG SUBSTANCE; NALMEFENE HYDROCHLORIDE DRUG SUBSTANCE.

API / Drug Master Files

PURISYS LLC holds 7 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NALMEFENE HYDROCHLORIDE DRUG SUBSTANCEActive2024-08-30
• PSILOCYBINActive2023-01-31
• DRONABINOL DRUG SUBSTANCEActive2021-10-12
• NABILONE DRUG SUBSTANCEActive2020-12-15
• CANNABIDIOL DRUG SUBSTANCEActive2019-02-22
• DEXMETHYLPHENIDATE HYDROCHLORIDEActive2016-05-27
• DRONABINOL DRUG SUBSTANCE IN SESAME OILActive2007-07-16
• DRONABINOL, 10% IN SESAME OILInactive2006-04-07

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to PURISYS LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.